Synthesis of pseudo-C-nucleosides
1243
ethyl acetate:toluene); 1H NMR (250.13 MHz, CDCl3):
d = 8.68 (s, NH), 8.04 (s, H-10), 7.26–6.87 (m, 10H,
C6H5), 6.34 (s, H-6), 6.03 (d, J = 3.7 Hz, H-1), 5.44 (d,
J = 3.2 Hz, H-4), 4.64 (d, J = 3.7 Hz H-2,), 4.50 and 4.35
(AB system, J = 11.7 Hz, CH2C6H5), 4.43 (d, J = 3.2 Hz,
H-3), 4.17 (q, J = 6.9 Hz, CH2CH3), 1.56 and 1.37 [2 s,
C(CH3)2], 1.27 (t, J = 6.9 Hz, CH2CH3) ppm; 13C NMR
(62.9 MHz, CDCl3): d = 166.6 (CO2Et), 146.6 (C-5),
143.4 (C-1, CH2C6H5), 137.1 (C-1, C6H5), 133.8 (C-10),
129.2, 128.1, 128.0, 127.9, 127.6, 120.7, 112.7 (CH, C6H5),
116.6 (C-6), 111.8 [C(CH3)2], 104.1 (C-1), 83.1 (C-2), 82.8
(C-3), 78.7 (C-4), 72.3 (CH2C6H5), 60.0 (CH2CH3), 27.0,
26.4 [C(CH3)2], 14.2 (CH2CH3) ppm; IR (neat): vꢀ = 3,241
hour by TLC. The mixture was concentrated after cooling
and purified by CC. 13 was obtained in 66% yield (0.30 g)
by reaction with 9; 10 reacted with 4 to form 14 in 61%
yield (0.27 g); 11 led to 17 in 69% yield (0.31 g); 12 led to
16 in 45% yield (0.16 g).
Ethyl 3-O-benzyl-5,6-dideoxy-5-C-(methoxycarbonylhy-
drazonomethyl)-1,2-O-isopropylidene-a-D-xylo-hept-5-
enofuranuronate (13, C22H28N2O8)
The obtained residue was purified by CC eluted with a 1:10
mixture of ethyl acetate:toluene. Syrup; Rf = 0.63 (4:1
ethyl acetate:toluene); 1H NMR (250.13 MHz, CDCl3):
d = 8.95 (s, NH), 7.78 (s, H-10), 7.50–7.30 (m, C6H5), 6.74
(br s, H-6), 5.97 (d, J = 3.7 Hz, H-1), 5.91 (d, J = 2.9 Hz,
H-4), 4.60 (d, J = 3.7 Hz, H-2), 4.53 and 4.40 (AB system,
J = 11.8 Hz, CH2C6H5), 4.33 (d, 1H, H-3), 4.10 (q,
J = 7.0 Hz, CH2CH3), 3.79 (s, OCH3), 1.50 and 1.30
[2 s, C(CH3)2], 1.24 (t, CH2CH3) ppm; 13C NMR
(62.9 MHz, CDCl3): d = 165.3 (CO2Et), 154.0 (CO2Me),
146.3 (C-5), 142.2 (C-10), 136.8 (C-1, C6H5), 128.1, 128.0,
127.6 (CH, C6H5), 117.8 (C-6), 112.0 [C(CH3)2], 104.8 (C-
1), 83.3 (C-3), 82.8 (C-2), 76.6 (C-4), 72.2 (CH2C6H5),
60.2 (CH2CH3), 52.6 (OCH3), 26.7, 26.2 [C(CH3)2], 13.9
(CH2CH3) ppm; IR (neat): vꢀ = 3,239 (NH), 1,782 (C=O),
(NH), 1,723 (C=O) cm-1
.
4-(3-O-Benzyl-1,2-O-isopropylidene-a-D-threo-furanos-4-
yl)pyridazin-6-one (16, C18H20N2O5)
The obtained residue was purified by CC eluted with a 1:3
mixture of ethyl acetate:toluene. Syrup; Rf = 0.22 (5:1
1
ethyl acetate:methanol); H NMR (250.13 MHz, CDCl3):
d = 12.12 (br s, H-1), 7.75 (d, J = 1.9 Hz, H-3), 7.30–7.06
(m, C6H5), 6.89 (s, H-5), 6.09 (d, J = 3.7 Hz, H-10), 5.05
(d, J = 2.5 Hz, H-40), 4.72 (d, J = 3.7 Hz, H-20), 4.56 and
4.34 (AB system, J = 12.1 Hz, CH2C6H5), 4.29 (d,
J = 2.5 Hz, H-30), 1.54 and 1.37 [2 s, C(CH3)2] ppm;
13C NMR (62.9 MHz, CDCl3): d = 162.0 (C-6), 142.7 (C-
4), 137.0 (C-3), 136.2 (C-1, C6H5), 128.6, 128.3, 127.8
(CH, C6H5), 126.6 (C-5), 112.3 [C(CH3)2], 105.2 (C-10),
82.4 (C-30), 82.4 (C-20), 78.8 (C-40), 72.1 (CH2C6H5), 26.8
and 26.1 [C(CH3)2] ppm; IR (neat): vꢀ = 3,241 (NH), 1,784
1,721 (C=O) cm-1
.
Ethyl 5-C-(benzoylhydrazonomethyl)-3-O-benzyl-5,6-dide-
oxy-1,2-O-isopropylidene-a-D-xylo-hept-5-enofuranur-
onate (14, C27H30N2O7)
The obtained residue was purified by CC eluted with a 1:5
mixture of ethyl acetate:toluene. Syrup; Rf = 0.39 (1:2
ethyl acetate:toluene); 1H NMR (250.13 MHz, CDCl3):
d = 10.41 (s, NH), 8.19 (s, H-10), 7.86 (d, J = 7.5 Hz,
C6H5), 7.46–7.16 (m, 8H, C6H5), 6.85 (s, H-6), 5.91 (d,
J = 3.9 Hz, H-1), 5.82 (d, J = 2.9 Hz, H-4), 4.54–4.49
(m, H-2, CH2C6H5), 4.39 (AB system, J = 11.8 Hz,
CH2C6H5), 4.30 (d, H-3), 4.07 (q, J = 6.9 Hz, CH2CH3),
1.44 and 1.25 [2 s, C(CH3)2], 1.23 (t, CH2CH3) ppm; 13C
NMR (62.9 MHz, CDCl3): d = 165.5 (CO2Et), 164.2
(COPh), 145.8 (C-5), 145.2 (C-10), 136.7 (C-1, CH2C6H5),
132.6 (C-1, C6H5), 131.8, 128.5, 128.2, 127.8, 127.7,
127.6, 127.5 (CH, C6H5), 118.9 (C-6), 111.9 [C(CH3)2],
104.9 (C-1), 83.4 (C-3), 82.9 (C-2), 78.0 (C-4), 72.4
(CH2C6H5), 60.3 (CH2CH3), 26.7 and 26.2 [C(CH3)2], 13.9
(CH2CH3) ppm; IR (neat): vꢀ = 3,243 (NH), 1,780 (C=O),
1,720 (C=O) cm-1; ESI(?)-HRMS: found 495.2119
(495.2126 calcd for C27H31N2O7).
(C=O), 1,592 (C=C) cm-1
; ESI(?)-HRMS: found
345.1442 (345.1450 calcd for C18H21N2O5).
Ethyl 4-(3-O-benzyl-1,2-O-isopropylidene-a-D-threo-
furanos-4-yl)-1-phenylpyrazole-3-carboxylate
(17, C26H28N2O6)
The obtained residue was purified by CC eluted with a 1:20
mixture of ethyl acetate:toluene. Syrup; Rf = 0.58 (1:2
ethyl acetate:toluene); 1H NMR (250.13 MHz, CDCl3):
d = 8.12 (s, H-5), 7.75–7.04 (m, C6H5), 6.07 (d,
J = 3.8 Hz, H-10), 5.74 (d, J = 2.9 Hz, H-40), 4.74 (d,
J = 3.8 Hz, H-20), 4.48 and 4.23 (AB system, J = 12 Hz,
CH2C6H5), 4.36–4.28 (m, H-30, CH2CH3), 1.57 and 1.37
[2 s, C(CH3)2], 1.33 (t, J = 7.2 Hz, CH2CH3) ppm; 13C
NMR (62.9 MHz, CDCl3): d = 162.2 (CO2Et), 140.7 (C-
4), 139.5 (C-1, C6H5-N), 137.2 (C-1, C6H5), 129.1 (C-5),
129.4, 128.3, 127.8, 127.7, 127.5, 119.9 (CH, C6H5), 122.1
(C-3), 111.8 [C(CH3)2], 104.5 (C-10), 83.4 (C-20), 81.6 (C-
30), 76.0 (C-40), 72.2 (CH2C6H5), 61.1 (CH2CH3), 26.9 and
26.3 [C(CH3)2], 14.2 (CH2CH3) ppm; IR (neat): vꢀ = 1,723
Ethyl 3-O-benzyl-5,6-dideoxy-5-C-(phenylhydrazonometh-
yl)-1,2-O-isopropylidene-a-D-xylo-hept-5-enofuranuronate
(15, C26H30N2O6)
(C=O), 1,595 (C=C) cm-1
465.2008 (465.2026 calcd for C26H29N2O6).
; ESI(?)-HRMS: found
The obtained residue was purified by CC eluted with a 1:10
mixture of ethyl acetate:toluene. Syrup, Rf = 0.47 (1:2
123